FDA Inspection 1223147 — ReproTech LLC

ReproTech LLC — FEI 3006185751

The FDA completed an inspection of ReproTech LLC on Nov 16, 2023 in Reno, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 16, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Reno, NV (United States)